Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2020

Aug 13, 2020

BUY
$46.85 - $61.05 $318,580 - $415,140
6,800 Added 755.56%
7,700 $453,000
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $1.3 Million - $1.57 Million
-24,100 Reduced 96.4%
900 $54,000
Q2 2017

Aug 14, 2017

BUY
N/A
25,000
25,000 $1.27 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.